Daunorubicin liposomal

Daunorubicin liposomal
Trade Name
Orphan Indication Acute myeloid leukemia
USA Market Approval USA
USA Designation Date 2008-09-05 00:00:00
Sponsor Diatos USA, LLC;15310 Amberly Drive;Tampa, Florida, 33647
Related Access Program
Children’s Hospital Los Angeles – Acute myeloid leukemia Jazz Pharmaceuticals – Secondary AML Celator Pharmaceuticals – Secondary AML University of California, San Francisco – Acute myeloid leukemia Emory University – Acute myeloid leukemia